Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidney M Wolfe

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|June 12, 2015
Selective clinical trial reporting: betraying trial participants, harming patientsSidney M Wolfe
BMJ (Clinical Research Ed.)|December 4, 2014
Author's reply to HackettSidney M Wolfe
Journal of General Internal Medicine|January 22, 2003
Remedies needed to address the pathology in reporting adverse reactions and Food and Drug Administration use of reportsSidney M Wolfe
Pharmacoepidemiology and Drug Safety|January 7, 2003
Drug safety withdrawals: who is responsible for notifying patients?Sidney M Wolfe
Archives of Internal Medicine|November 16, 2011
Early signals of harmful drugsSidney M Wolfe
BMJ (Clinical Research Ed.)|August 24, 2013
When EMA and FDA decisions conflict: differences in patients or in regulation?Sidney M Wolfe
JAMA Internal Medicine|September 4, 2019
The Public Health Urgency of a Temporary FDA Moratorium on New Opioid ApprovalsSidney M Wolfe
BMJ (Clinical Research Ed.)|March 1, 2014
Increased heart attacks in men using testosterone: the UK importantly lags far behind the US in prescribing testosteroneSidney M Wolfe
Science (New York, N.Y.)|April 19, 2003
Medicine. Ephedra--scientific evidence versus money/politicsSidney M Wolfe
BMJ (Clinical Research Ed.)|December 20, 2013
Escalating criminal and civil violations: pharma has corporate integrity? Not reallySidney M Wolfe
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|June 12, 2015
Selective clinical trial reporting: betraying trial participants, harming patientsSidney M Wolfe
BMJ (Clinical Research Ed.)|December 4, 2014
Author's reply to HackettSidney M Wolfe
Journal of General Internal Medicine|January 22, 2003
Remedies needed to address the pathology in reporting adverse reactions and Food and Drug Administration use of reportsSidney M Wolfe
Pharmacoepidemiology and Drug Safety|January 7, 2003
Drug safety withdrawals: who is responsible for notifying patients?Sidney M Wolfe
Archives of Internal Medicine|November 16, 2011
Early signals of harmful drugsSidney M Wolfe
BMJ (Clinical Research Ed.)|August 24, 2013
When EMA and FDA decisions conflict: differences in patients or in regulation?Sidney M Wolfe
JAMA Internal Medicine|September 4, 2019
The Public Health Urgency of a Temporary FDA Moratorium on New Opioid ApprovalsSidney M Wolfe
BMJ (Clinical Research Ed.)|March 1, 2014
Increased heart attacks in men using testosterone: the UK importantly lags far behind the US in prescribing testosteroneSidney M Wolfe
Science (New York, N.Y.)|April 19, 2003
Medicine. Ephedra--scientific evidence versus money/politicsSidney M Wolfe
BMJ (Clinical Research Ed.)|December 20, 2013
Escalating criminal and civil violations: pharma has corporate integrity? Not reallySidney M Wolfe
Pageof 5